DiaMedica Therapeutics (DMAC) vs Rezolute (RZLT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
DiaMedica Therapeutics (DMAC) has outperformed Rezolute (RZLT) over the past year, gaining 16.5% versus a loss of 50.0%. Over five years, DMAC leads with a +94.9% price change compared with -34.1% for RZLT. DiaMedica Therapeutics is the larger company by market cap ($430.9 million vs $423.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DMAC | RZLT |
|---|---|---|
| Share price | $7.99 | $4.38 |
| Market cap | $430.87M | $423.64M |
| 1-day change | -1.72% | +1.39% |
| YTD return | +0.38% | +85.59% |
| 1-year return | +16.47% | -50.00% |
| 5-year return | +94.88% | -34.14% |
| EPS (TTM) | $-0.72 | $-0.75 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.42 | $11.46 |
| 52-week low | $5.25 | $1.07 |
| Distance from 52-week high | -23.32% | -61.77% |
| Average volume | 177.47K | 1.49M |
| Shares outstanding | 53.93M | 96.72M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DMAC has outperformed RZLT by 66.5 percentage points over the past year.
DMAC vs RZLT FAQ
Which is bigger, DiaMedica Therapeutics or Rezolute?
DiaMedica Therapeutics (DMAC) is larger, with a market capitalization of $430.87M compared with $423.64M for Rezolute (RZLT).
Which stock has performed better over the past year, DMAC or RZLT?
DMAC returned +16.47% over the past 12 months, compared with -50.00% for RZLT (price return, excluding dividends). Past performance does not predict future results.
Are DiaMedica Therapeutics and Rezolute in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.